5 Best Oil Service Stocks For 2015

5 Best Oil Service Stocks For 2015: Jazz Pharmaceuticals Inc.(JAZZ)

Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products to meet unmet medical needs. The company markets Xyrem, a sodium oxybate oral solution for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy; and Luvox CR extended-release capsules for the treatment of obsessive compulsive disorder. Its product candidates under clinical development include JZP-6, a Phase III pivotal clinical trials completed product for the treatment of fibromyalgia; and JZP-8, an intranasal formulation of clonazepam, which has completed Phase II clinical trial for the treatment of acute repetitive seizures in epilepsy and solid oral dosage forms of sodium oxybate. The company sells its products through specialty sales force targeting sleep specialists, psychiatrists, neurologists, and pulmonologists. Jazz Pharmaceuticals, Inc. was founded in 2003 and is headq uartered in Palo Alto, California.

Advisors' Opinion:

• [By Selena Maranjian]

  For example, consider Lone Pine Capital, founded by Steve Mandelin 1997. Lone Pine is one of the biggest hedge fund companies, and it has reportedly outperformedthe S&P 500 handily since inception. Its reportable stock portfolio totaled $23 billionin value as of March 31, 2014. According to its recently released 13F statement, Lone Pine established or added to positions in Jazz Pharmaceuticals plc (NASDAQ: JAZZ  ) , SouFun Holdings Ltd (NYSE: SFUN  ) , and Valeant Pharmaceuticals International (NYSE: VRX  ) .

• [By Jake L'Ecuyer]

  Shares of Jazz Pharmaceuticals Public Limited Company (NASDAQ: JAZZ) got a boost, shooting up 7.77 percent to $123.65 after the company announced its plans to buy Gentium SpA (NASDAQ: GENT) for around $1 billion.

• [By Jon C. Ogg]

  Jazz ! Pharmaceuticals PLC (NASDAQ: JAZZ) was shown to have a good balance sheet and in the middle of trying to close the Gentium acquisition for close to $1 billion. Merrill Lynch thinks that it will remain active after closing the deal and will focus on differentiated products that are on market or close to market. Those would likely need to have high margins and a targeted audience that can be handled with a relatively small sales force. Jazz has an $8 billion market cap and has made 4 acquisitions in the last decade.

• [By Myra Ramdenbourg]

  Jazz Pharmaceuticals PLC (JAZZ): EVP and CFO Kathryn E. Falberg Sold 2,000 Shares

  On 02/12/2014, EVP and CFO Kathryn E. Falberg sold 2,000 shares at an average price of $157. The price of the stock has decreased by 1.12% since. Jazz Pharmaceuticals PLC has a market cap of $9.01 billion and its shares were traded at around $155.24. The company has a P/E ratio of 44.00 and P/S ratio of 10.96. Over the past five years, Jazz Pharmaceuticals PLC had an annual average earnings growth of 68.30%.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/5-best-oil-service-stocks-for-2015-3.html